Allegro names Michael Webb CEO
This article was originally published in Scrip
Allegro Diagnostics, a molecular diagnostics company focused developing treatments for lung cancer, has appointed Michael Webb president and chief executive officer, as well as electing him to its board of directors. Mr Webb previously served as founder, president and CEO of Anchor Therapeutics. He is currently the executive chairman of Vitrify.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.